4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0001209191-21-052272
Chief Financial Officer bought 40,372 shares at an average $6.51 ($262,660)
From the SEC's structured data for this filing
Trades in this filing
Alspaugh Jonathan · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-16 | Purchase : show line 1 in the form | +9,780 | $6.37 | $62,275 | 9,780 | D |
| 2021-08-17 | Purchase : show line 2 in the form | +23,392 | $6.50 | $151,985 | 33,172 | D |
| 2021-08-18 | Purchase : show line 3 in the form | +7,200 | $6.72 | $48,400 | 40,372 | D |
| Open-market purchases · 40,372 sh · avg $6.51 · $262,660 | ||||||
Loading xslF345X03/doc4.xml…